T. Kalincik Et Al. , "Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis," MULTIPLE SCLEROSIS JOURNAL , vol.21, no.9, pp.1159-1171, 2015
Kalincik, T. Et Al. 2015. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL , vol.21, no.9 , 1159-1171.
Kalincik, T., Jokubaitis, V., IZQUIERDO, G., DUQUETTE, P., GIRARD, M., Grammond, P., ... LUGARESI, A.(2015). Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL , vol.21, no.9, 1159-1171.
Kalincik, Tomas Et Al. "Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis," MULTIPLE SCLEROSIS JOURNAL , vol.21, no.9, 1159-1171, 2015
Kalincik, Tomas Et Al. "Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis." MULTIPLE SCLEROSIS JOURNAL , vol.21, no.9, pp.1159-1171, 2015
Kalincik, T. Et Al. (2015) . "Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis." MULTIPLE SCLEROSIS JOURNAL , vol.21, no.9, pp.1159-1171.
@article{article, author={Tomas Kalincik Et Al. }, title={Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis}, journal={MULTIPLE SCLEROSIS JOURNAL}, year=2015, pages={1159-1171} }